(Q57442965)

1

0 references

Ran Mo

2

0 references

Adriano Bellotti

3

0 references

Jianping Zhou

4

0 references

Zhen Gu

Advanced Functional Materials

5

0 references

language of work or name

English

0 references

publication date

2 January 2014

0 references

published in

0 references

volume

24

0 references

issue

16

0 references

page(s)

2295-2304

0 references

cites work

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Synergistic drug combinations tend to improve therapeutically relevant selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Combinatorial drug conjugation enables nanoparticle dual-drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

PSMA-targeted theranostic nanoplex for prostate cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Relationships between the structures of taxol and baccatine III derivatives and their in vitro action on the disassembly of mammalian brain and Physarum amoebal microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Cytokines in cancer pathogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

The TRAIL apoptotic pathway in cancer onset, progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Tumor necrosis factor, cancer and anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Antibody therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Caspases 3 and 7: key mediators of mitochondrial events of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Intrinsic tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Tailoring nanocarriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Consecutive targetable smart nanoprobe for molecular recognition of cytoplasmic microRNA in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Hyaluronidases: their genomics, structures, and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Increased hyaluronidase levels in breast tumor metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Protein nanocapsule weaved with enzymatically degradable polymeric network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Mechanisms of endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222

Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201303222